MonitorCRO USA specializes in providing biopharmaceutical companies with bioequivalence, pharmacokinetics and early phase (1/2a) studies.  Additionally we offer adjunct services for early clinical trial and pharmacokinetic studies including pharmacovigilance services and reporting, project management, statistical reports (in-house and outsourced) and study reports.  In coordination with our supplier company, MonitorCRO, we are able to provide timely and cost-effective biopharmaceutical services for all of your needs.

Our services include complete risk oversight by our team of FDA experienced auditors.  Our studies adhere to the required FDA Good Clinical Practice (GCP), Good Laboratories Practice (GLP) guidelines and all applicable International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) regulations.

Rest assured that when you select MonitorCRO USA you are getting the highest possible quality along with in-house medical expertise.  Our supplier company, MonitorCRO, has completed over 100 bioequivalence (BE) and bioavailability (BA) studies throughout Europe since 2000. Why pay more for your studies when you can get quality work at a lower cost?